Recently, the Yonsei Cancer Center (YCC) at Severance Hospital was certified by FDA, USA as the top grade; *NAI (No action indicated), for its conduct in clinical research. FDA performed this inspection to make sure the quality of the study and confidence of result for the trial with Alimta from Lilly (PI: Prof. Kim JH). YCC has conducted a clinical research study, in year 2005-2007, with Alimta (ingredient: Pemetrexed), which is a chemotherapy treatment for non-small cell lung cancer. This trial was performed on patients with advanced lung cancer whereby no standard treatment is available for their condition. Results from this clinical trial were well-collected and properly documented. The well conduct of this trial has resulted YCC being awarded the NAI certification. This awarded certificate is one of the official evidence that documents the great improvement in the quality of clinical research in Korea.

Link: http://www.dailymedi.com/news/opdb/index.php?cmd=view&dbt=article&cate=class2&code=110424